KM

Kenzie Maclsaac

Partner at Cure Ventures

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biomarker Discovery
Statistical Computing
Machine Learning
Genomics
Text Mining
Data Analysis
Immunology
Oncology
Bioinformatics
Drug Discovery
Computational Biology
Biomarkers

Education

Lists including Kenzie

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

CV
Cure Ventures

2022

  • Partner

    2022

BM
Bristol Myers Squibb

2018 - 2022

  • Senior Director

    2021 - 2022

  • Director, Translational Bioinformatics

    2018 - 2021

F
FogPharma

2018 - 2018

  • Director of Translational Bioinformatics

    2018 - 2018

NI
Novartis Institutes for BioMedical Research

2014 - 2018

  • Senior Investigator II - Bioinformatics

    2014 - 2018

M
Merck

2009 - 2014

  • Associate Principal Scientist

    2009 - 2014

    Genomics and target discovery for immunology and oncology drug discovery programs.

M
MIT

2009 - 2010

  • Research Affiliate

    2009 - 2010